Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research-Reference-Cited by-同舟云学术

Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research

Published:2014-07-28 Issue: Volume:5 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Tuntland Tove,Ethell Brian,Kosaka Takatoshi,Blasco Francesca,Zang Richard Xu,Jain Monish,Gould Ty,Hoffmaster Keith

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference65 articles.

1. The role of mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational research of biologics;Agoram;Drug Discov. Today,2007

2. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore;Ambrose;Clin. Infect. Dis,2007

3. Application of in vivo animal models to characterize the pharmacokinetic and pharmacodynamic properties of drug candidates in discovery settings;Amore;Comb. Chem. High Throughput Screen,2010

4. Animal models pharmacokinetics and pharmacodynamics: a critical review;Andes;Int. J. Antimicrob. Agents,2002

5. Plasma/serum protein binding determinations;Banker;Curr. Drug Metab,2008

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The promise of Synovial Joint-on-a-Chip in rheumatoid arthritis;Frontiers in Immunology;2024-09-11

2. Can we do better with Mylotarg? Model-based assessment of opportunities to improve therapeutic index;Toxicology and Applied Pharmacology;2024-09

3. Upholding or Breaking the Law of Superposition in Pharmacokinetics;Biomedicines;2024-08-13

4. The Revolutionary Role of Artificial Intelligence (AI) in Pharmaceutical Sciences;Indian Journal of Pharmaceutical Education and Research;2024-08-10

5. A Phase I, Open-Label, Sequential, Single-Dose Clinical Trial to Evaluate the Pharmacokinetic, Pharmacodynamic, and Safety of IVL3001, a Finasteride-Based Novel Long-Acting Injection for Androgenetic Alopecia;Advances in Therapy;2024-06-04